drugset / Trial / NCT06562114
A Phase 1 Safety and Tolerability Study of TML-6 in Healthy and Elderly Volunteers for Alzheimer's Disease Treatment
RandomizedSequentialDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability, single-ascending dose (SAD), multiple-ascending dose (MAD), food effect, and pharmacokinetic (PK) Study of TML-6.
Timeline
- Start
- 2024-07-11
- Primary completion
- 2025-07-18
- Completion
- 2025-08-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TML-6 | Small molecule | — | Oral |
Indications
No indication recorded.